ES8602747A1 - Un procedimiento para la preparacion de derivados del acido 4-amino-4,5-dihidro-2-tiofencarboxilico - Google Patents

Un procedimiento para la preparacion de derivados del acido 4-amino-4,5-dihidro-2-tiofencarboxilico

Info

Publication number
ES8602747A1
ES8602747A1 ES541637A ES541637A ES8602747A1 ES 8602747 A1 ES8602747 A1 ES 8602747A1 ES 541637 A ES541637 A ES 541637A ES 541637 A ES541637 A ES 541637A ES 8602747 A1 ES8602747 A1 ES 8602747A1
Authority
ES
Spain
Prior art keywords
gamma
processes
preparation
aminobutyric acid
acid transaminase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES541637A
Other languages
English (en)
Other versions
ES541637A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of ES8602747A1 publication Critical patent/ES8602747A1/es
Publication of ES541637A0 publication Critical patent/ES541637A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE ACIDO 4-AMINO-4,5-DIHIDRO-2-TIOFENCARBOXILICO. CARACTERIZADO POR SOMETER A REDUCCION UN COMPUESTO DE FORMULA (II) PARA PRODUCIR EL CORRESPONDIENTE ALCOHOL EL CUAL SE SOMETE A REACCION DE DESHIDRATACION PARA PRODUCIR EL CORRESPONDIENTE COMPUESTO DE FORMULA (II) AL QUE SE ELIMINA EL GRUPO PROTECTOR, OBTENIENDOSE EL COMPUESTO DE FORMULA GENERAL (I) DONDE R ES HIDROGENO O ALQUILO C1-6 Y SUS SALES. COMPUESTOS QUE ACTUAN COMO INHIBIDORES DE LA ACIDO-8-AMINOBUTIRICO-TRANSAMINASA POR LO QUE SON UTILES EN EL TRATAMIENTO DE LA EPILEPSIA.
ES541637A 1983-10-11 1985-03-27 Un procedimiento para la preparacion de derivados del acido 4-amino-4,5-dihidro-2-tiofencarboxilico Granted ES541637A0 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54074383A 1983-10-11 1983-10-11
US54074583A 1983-10-11 1983-10-11
US54074483A 1983-10-11 1983-10-11

Publications (2)

Publication Number Publication Date
ES8602747A1 true ES8602747A1 (es) 1985-12-01
ES541637A0 ES541637A0 (es) 1985-12-01

Family

ID=27415337

Family Applications (4)

Application Number Title Priority Date Filing Date
ES536669A Granted ES536669A0 (es) 1983-10-11 1984-10-10 Un procedimiento para la preparacion de acido 4-amino-4, 5-dihidro-2-furancarboxilico
ES541637A Granted ES541637A0 (es) 1983-10-11 1985-03-27 Un procedimiento para la preparacion de derivados del acido 4-amino-4,5-dihidro-2-tiofencarboxilico
ES541636A Expired ES8602746A1 (es) 1983-10-11 1985-03-27 Un procedimiento para la preparacion de derivados del acido 4-amino-4,5-dihidro-2-tiofencarboxilico
ES541635A Expired ES8602731A1 (es) 1983-10-11 1985-03-27 Un procedimiento para la preparacion de derivados del acido 4-(((alcoxi sustituido)carbonil)-amino)-4,5-dihidro-2-furan-carboxilico

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES536669A Granted ES536669A0 (es) 1983-10-11 1984-10-10 Un procedimiento para la preparacion de acido 4-amino-4, 5-dihidro-2-furancarboxilico

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES541636A Expired ES8602746A1 (es) 1983-10-11 1985-03-27 Un procedimiento para la preparacion de derivados del acido 4-amino-4,5-dihidro-2-tiofencarboxilico
ES541635A Expired ES8602731A1 (es) 1983-10-11 1985-03-27 Un procedimiento para la preparacion de derivados del acido 4-(((alcoxi sustituido)carbonil)-amino)-4,5-dihidro-2-furan-carboxilico

Country Status (15)

Country Link
EP (1) EP0145875B1 (es)
JP (1) JPS60104077A (es)
KR (1) KR890001008B1 (es)
AU (1) AU569915B2 (es)
CA (1) CA1241963A (es)
DE (1) DE3485514D1 (es)
DK (1) DK483684A (es)
ES (4) ES536669A0 (es)
GR (1) GR80568B (es)
HU (1) HU201038B (es)
IE (1) IE57589B1 (es)
IL (1) IL73109A (es)
NO (1) NO168579C (es)
NZ (1) NZ209803A (es)
PT (1) PT79336B (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1473757A (en) * 1974-08-05 1977-05-18 Teikoku Chem Ind Co Ltd Ureylenethiophanes and their related compounds and production thereof

Also Published As

Publication number Publication date
PT79336B (en) 1986-09-08
ES541636A0 (es) 1985-12-01
GR80568B (en) 1985-02-07
IL73109A (en) 1990-02-09
NO168579C (no) 1992-03-11
ES8602746A1 (es) 1985-12-01
IL73109A0 (en) 1984-12-31
KR890001008B1 (ko) 1989-04-18
DK483684D0 (da) 1984-10-10
IE57589B1 (en) 1993-01-13
ES8603857A1 (es) 1986-01-01
NO168579B (no) 1991-12-02
EP0145875A3 (en) 1988-03-02
KR850002969A (ko) 1985-05-28
JPH0587513B2 (es) 1993-12-16
DE3485514D1 (de) 1992-03-26
CA1241963A (en) 1988-09-13
NZ209803A (en) 1987-02-20
DK483684A (da) 1985-04-12
NO844066L (no) 1985-04-12
EP0145875A2 (en) 1985-06-26
ES536669A0 (es) 1986-01-01
ES541635A0 (es) 1985-12-01
HUT36813A (en) 1985-10-28
AU3389784A (en) 1985-04-18
AU569915B2 (en) 1988-02-25
ES541637A0 (es) 1985-12-01
HU201038B (en) 1990-09-28
JPS60104077A (ja) 1985-06-08
ES8602731A1 (es) 1985-12-01
EP0145875B1 (en) 1992-02-19
PT79336A (en) 1984-11-01
IE842584L (en) 1985-04-11

Similar Documents

Publication Publication Date Title
DE3476535D1 (en) Process for the preparation of esters of (meth)-acrylic acid, and their use
PT83509A (en) Process for the preparation of pharmaceutical compositions with controlled release of metoprolol
NZ303372A (en) Use of (s)-oxybutynin and (s)-desethyloxybutynin to treat urinary incontinence
ES8406472A1 (es) Procedimiento para preparar imidazolilalquiltien-2-il-tetrahidropiridazinas
ES2058029A1 (es) Proceso para la produccion de sales del acido clavulanico.
AU565134B2 (en) Amine salts of dithio-phosphoric, phosphinic and phosphonic acid esters
MY104521A (en) Treatment of depression.
AU2644384A (en) Gamma-vinyl gamma-aminobutyric acid composition
ES8603857A1 (es) Un procedimiento para la preparacion de acido 4-amino-4, 5-dihidro-2-furancarboxilico
ES8507098A1 (es) Procedimiento para la preparacion de l(-)carnitina en forma de cloridrato o en forma de su sal interna.
EG17886A (en) Process for preparing niflumie acid morpholinoethyl ester diniflumate,used in therapeutics as analgesic and anti-inflammatory
MY101747A (en) Dihydroorotic acids derivative, processes for preparing the same
HUT34726A (en) Process for preparing esters of pantethine and pantetheine
ES8403487A1 (es) "procedimiento para la preparacion de n-(2-metoxietil)-noroximorfona".
PT72273B (en) Process for preparing esters of l-arginine in aqueous solution
DE3564805D1 (en) Salts of alkenylsuccinamic acids, process for their preparation and their use as corrosion inhibitors
EP0117740A3 (en) Process for producing l-glutamic acid by fermentation and mutant microorganisms for use therein
EP0034750A3 (en) N-substituted imidodicarboxylic acid diaryl esters, process for their preparation and their use as intermediates
JPS525755A (en) Process for preparation of 3-amino-4-homotwistane and its acid salts
ES8700226A1 (es) Un procedimiento para la preparacion en forma cristalina de una mezcla de sales diastereomericas del ester 1-pivaloiloxietilico de (s)-3-(3,4-dihidroxifenil)-2-metilalanina
PH25184A (en) 4-amino-4,5-dihydro-2-furancarboxylic acid and esters thereof useful as y-aminobutyric acid transaminase inhibitors
HUT36130A (en) Process for preparing aminoalkyl-imidazo-thidaiazolyl-alkane-carboxylic acid amides and pharmaceutical compositions thereof as active substances
PH20827A (en) 4-amino-4,5-dihydro-2-thiophenecarboxylic acid and esters thereof as y-aminobutyric acid transaminase inhibitors
JPS51130590A (en) Process for preparing l-(+)-tartaric acid
ES8105392A1 (es) Procedimiento de obtencion de una solucion de aminoacidos y peptidos de origen animal por proceso enzimatico

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519